What's in BioCryst Pharmaceuticals's pipeline?

BioCryst Pharmaceuticals has 10 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 4 in Phase 2, 5 in Phase 1.

Which companies overlap with BioCryst Pharmaceuticals's portfolio?

Top competitors by shared drug class: Aldeyra Therapeutics, Inc., Alexion Pharmaceuticals, Inc., CSL Behring, Haaglanden Medical Centre, InflaRx GmbH.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/biocryst-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

BioCryst Pharmaceuticals — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BioCryst Pharmaceuticals pipeline: 0 marketed, 0 filed, 1 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 4 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
BCX7353 capsules	BCX7353 capsules	phase 3	Plasma kallikrein inhibitor	Plasma kallikrein (Factor XIa)	Immunology / Rare Disease

Therapeutic area mix

Immunology · 2
Immunology / Rare Disease · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aldeyra Therapeutics, Inc. · 1 shared drug class
Alexion Pharmaceuticals, Inc. · 1 shared drug class
CSL Behring · 1 shared drug class
Haaglanden Medical Centre · 1 shared drug class
InflaRx GmbH · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BioCryst Pharmaceuticals:

Cite this brief

Drug Landscape (2026). BioCryst Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/biocryst-pharmaceuticals. Accessed 2026-06-09.